Class 3 Recall on Lynparza Capsules 50mg

Class 3 Recall on Lynparza Capsules 50mg

AstraZeneca is recalling batch NG327 as the level of olaparib polymorphic form L exceeds the registered specification limit. As a precautionary measure, the other batches listed are also being recalled as they may exceed the limit before the end of their shelf life.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code Product Description Supplier Affected Batches
Alliance do not stock Lynparza Capsules 50mg AstraZeneca NG327

For stock enquiries please contact AstraZeneca Supply Chain: 0800 783 0033 or andy.bailey@astrazeneca.com

For medical information enquiries please contact AstraZeneca Medical Information: 0800 783 0033 or medical.informationuk@astrazeneca.com


Please return all affected stock to your original supplier for credit. Alliance Healthcare do not stock therefore we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.